Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Stand-Alone Adjuvant Immunotherapy for Early TNBC?
The role of adjuvant immunotherapy in triple-negative breast cancer (TNBC) remains uncertain. Standard therapy for TNBC includes neoadjuvant pembrolizumab with chemotherapy followed by pembrolizumab, with or without chemotherapy, after surgery. One lingering uncertainty has been whether continuing immunotherapy after surgery…
English